| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 932.79B | 922.52B | 950.66B | 906.02B | 821.57B | 748.72B |
| Gross Profit | 124.52B | 123.66B | 119.61B | 87.36B | 109.83B | 109.76B |
| EBITDA | 91.72B | 89.17B | 89.25B | 60.33B | 85.01B | 73.81B |
| Net Income | 27.64B | 22.39B | 23.08B | 10.36B | 44.42B | 15.95B |
Balance Sheet | ||||||
| Total Assets | 1.18T | 1.20T | 1.18T | 1.17T | 1.08T | 1.04T |
| Cash, Cash Equivalents and Short-Term Investments | 104.46B | 119.84B | 90.02B | 99.70B | 126.45B | 117.49B |
| Total Debt | 216.64B | 231.26B | 194.04B | 184.15B | 111.48B | 128.70B |
| Total Liabilities | 499.94B | 506.79B | 483.10B | 493.88B | 417.99B | 384.44B |
| Stockholders Equity | 649.75B | 666.97B | 665.71B | 643.05B | 637.35B | 625.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 60.44B | 12.24B | -82.08B | 28.14B | 15.28B |
| Operating Cash Flow | 0.00 | 94.06B | 64.58B | -18.86B | 75.42B | 79.33B |
| Investing Cash Flow | 0.00 | -51.11B | -52.44B | -57.04B | -27.17B | -68.41B |
| Financing Cash Flow | 0.00 | -18.77B | -27.81B | 41.53B | -42.19B | -16.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥435.88B | 10.13 | 6.90% | 2.71% | 1.04% | 110.81% | |
77 Outperform | ¥105.25B | 7.99 | 7.53% | 3.01% | 6.27% | 18.00% | |
74 Outperform | ¥76.67B | 12.05 | ― | 6.64% | 1.64% | -3.80% | |
73 Outperform | ¥56.63B | 9.03 | ― | 3.31% | 2.25% | 30.32% | |
72 Outperform | ¥32.02B | 6.58 | ― | 6.14% | -5.39% | 50.53% | |
70 Outperform | ¥135.57B | 4.25 | 10.46% | 2.35% | 2.18% | 84.02% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |